cisplatin,nivolumab,ipilimumab
bms
['nivolumab', 'cisplatin', 'urothelial', 'renal,(-adrenal)', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'ipilimumab', 'nivo']
neoadjuvant nivolumab + ipilimumab in cisplatin-ineligible patients with upper tract urothelial cancer #utuc. presented by . #gu23 written coverage by &gt; 
Largest global online community of #urological medical professionals & patients. #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology